The Short Version
Women over 40 face a distinct set of nutritional priorities: accelerating bone density loss, perimenopause-related sleep and mood disruption, rising cardiovascular risk, and declining absorption of certain nutrients. The supplements with the strongest evidence for this life stage are vitamin D3+K2, magnesium glycinate, omega-3 fatty acids, and vitamin B12. Everything else is context-dependent. If you leave this page with only one takeaway, get your vitamin D level tested - deficiency is near-universal in this demographic and the consequences for bone health are real and measurable.
Quick Picks
- Bone health priority: Vitamin D3 (2,000-4,000 IU/day) + Vitamin K2 MK-7 (100-200 mcg/day)
- Sleep and stress: Magnesium glycinate (200-400 mg elemental magnesium at bedtime)
- Cardiovascular and brain: Omega-3 fish oil (1-2g EPA+DHA/day, triglyceride form)
- Energy and nerve health: Vitamin B12 (methylcobalamin form, especially for women over 50)
- Hormonal stress support: Ashwagandha KSM-66 (600 mg/day)
Vitamin D3 + K2: The Non-Negotiable for Bone Health
Bone density loss accelerates significantly after 35 and sharpens further around perimenopause as estrogen - which protects bone - declines. Women lose an average of 2-3% of bone density per year in the years immediately surrounding menopause. Vitamin D3 is essential for calcium absorption: without adequate vitamin D, you absorb only 10-15% of dietary calcium. With sufficient levels, that rises to 30-40%.
The case for pairing it with vitamin K2 (specifically the MK-7 form) is the strongest in women at elevated cardiovascular risk. K2 activates osteocalcin, a protein that directs calcium into bones rather than arterial walls. The combination addresses both bone density and soft-tissue calcification simultaneously.
Target blood level: 40-60 ng/mL 25(OH)D. Most women without supplementation fall well below this. Dose: 2,000-4,000 IU D3 daily with the largest meal of the day (fat improves absorption by approximately 50%). K2 at 100-200 mcg MK-7 daily.
See our vitamin D3 scorecard for the best-tested products at each price point.
Boron is the lesser-known trace mineral in this stack: a 1987 metabolic ward trial in postmenopausal women showed 3 mg/day cut urinary calcium and magnesium loss, a small but credible mineral-retention effect that complements the D3+K2 foundation rather than replacing it.
Magnesium Glycinate: Sleep, Bone Density, and Stress
Magnesium deficiency is one of the most common micronutrient shortfalls in adult women, and its effects are wide-ranging. Magnesium is required for over 300 enzymatic reactions, including the conversion of vitamin D to its active form. An inadequate magnesium level limits the benefit of vitamin D supplementation regardless of dose.
For women over 40 specifically, three benefits are most clinically relevant. First, magnesium is involved in bone mineral density independent of calcium - a 2013 study found that each 100 mg/day increase in magnesium intake was associated with a 2% increase in whole-body bone density. Second, magnesium glycinate taken at bedtime improves sleep quality through its role in GABA receptor function and melatonin production - a 2012 RCT in elderly subjects found significant improvements in sleep time and quality with magnesium supplementation. This is particularly relevant during perimenopause when sleep disruption is common. Third, magnesium moderates the HPA axis stress response, which helps with the anxiety that often accompanies hormonal changes.
The glycinate form is preferred: it is well-absorbed, gentle on the GI tract, and the glycine component has independent calming properties. Avoid magnesium oxide - it is poorly absorbed and primarily functions as a laxative.
See our magnesium glycinate scorecard for detailed product comparisons.
If you are looking for a food-based alternative to melatonin tablets, tart cherry concentrate (1oz before bed) has small but real RCT data behind sleep efficiency improvements - the Pigeon 2010 trial in older adults with insomnia showed reduced wake-after-sleep-onset minutes.
Omega-3 Fish Oil: Cardiovascular Risk Reduction
Premenopausal estrogen provides meaningful cardiovascular protection. As estrogen declines, women's cardiovascular risk rises to approach men's within a decade of menopause. The Framingham Heart Study data show that women catch up to men in cardiovascular event rates by their late 60s.
Omega-3 fatty acids (EPA and DHA) have their strongest evidence base in cardiovascular outcomes. A meta-analysis of 13 randomized controlled trials found that omega-3 supplementation reduced the risk of heart attack by 11% and cardiovascular death by 10%. The VITAL trial found the most pronounced benefit in people with low fish consumption.
Additional benefits relevant to this demographic: DHA supports brain structure and may slow cognitive decline; EPA has anti-inflammatory effects that support joint health; and there is preliminary evidence for mood support in women with depressive symptoms.
For women noticing early memory or processing-speed changes, acetyl-L-carnitine at 1.5-3 g/day has modest but real meta-analysis support for slowing decline in mild cognitive impairment, and a separate signal for depressive symptoms in older adults. Effects build over 8-12 weeks.
Target dose: 1-2g combined EPA+DHA per day. Look for triglyceride form (better absorbed than ethyl ester) from brands with IFOS oxidation certification. See our fish oil scorecard for specific product grades.
For women whose blood pressure is creeping up post-menopause, aged garlic extract has measurable systolic-pressure benefit (roughly 7-9 mmHg in hypertensives) and stacks safely with omega-3 and magnesium. See our garlic extract scorecard. Nattokinase at 100mg/2,000 FU/day is a smaller-evidence option in the same conversation, with modest BP reductions in two RCTs - but it should never be combined with prescription anticoagulants without physician oversight.
Vitamin B12: Absorption Declines with Age
B12 absorption requires adequate stomach acid to release the vitamin from food proteins, and adequate intrinsic factor (a protein produced in the stomach) to transport it into the bloodstream. Both decline with age. By age 50, approximately 10-30% of adults have impaired B12 absorption from food. Those taking proton pump inhibitors (PPIs) or metformin face additional risk - both medications further impair B12 absorption.
B12 deficiency causes fatigue, peripheral neuropathy, cognitive changes, and megaloblastic anemia. The neurological symptoms can be subtle and develop gradually over years before a deficiency is detected on standard blood tests.
Supplemental B12 (especially in sublingual or methylcobalamin form) bypasses the absorption issues with food-bound B12, as it does not require intrinsic factor in the same way. The methylcobalamin form is the biologically active form; cyanocobalamin requires conversion and may not be as effective in people with genetic variations in methylation pathways. If you take a PPI or metformin, B12 testing and supplementation are worth discussing with your doctor.
See our vitamin B12 scorecard for tested products in methylcobalamin form.
Ashwagandha: Cortisol, Sleep, and Hormonal Transition
The perimenopause years bring elevated baseline cortisol in many women - the result of disrupted sleep, HPA axis changes, and the accumulated stress load of midlife. Elevated cortisol impairs sleep quality, promotes abdominal fat accumulation, and may worsen hot flashes. Ashwagandha's strongest evidence is for cortisol reduction and stress response modulation.
A 2019 RCT found that 600 mg/day KSM-66 ashwagandha significantly reduced cortisol levels and improved sleep quality over 8 weeks. A separate study in women reported improvements in sexual function and satisfaction, potentially relevant for women experiencing perimenopausal changes in libido. DHEA is sometimes recommended for the same population, with the strongest evidence in women with diagnosed adrenal insufficiency rather than healthy perimenopause; the cancer-history and androgenic side-effect flags make it a clinician-supervised choice, not a self-prescribe.
For men in this age range, L-arginine at 3-5g/day is the most-studied non-prescription option for mild ED, with the strongest effect when stacked with Pycnogenol; avoid it within 6 months of any cardiac event.
Important safety note: ashwagandha has thyroid-stimulating effects and should not be used by women with hyperthyroidism or Graves' disease. Women with autoimmune conditions should consult their physician first. See our full safety analysis at Is Ashwagandha Safe.
See our ashwagandha scorecard for products using KSM-66 at the studied 600 mg dose, and Ashwagandha in 2026: what the research actually confirms for the full evidence picture including the thyroid cautions.
Creatine, Yes, For Women Too
Creatine is often skipped in women's supplement lists because the historical research pool was overwhelmingly male. Newer female-specific trials show meaningful benefits for muscle strength, postmenopausal bone density, and cognitive function under stress, with no support for the bulking, hair-loss, or bloating concerns that show up on social media. See our creatine for women research review for what the evidence actually supports and the practical 3-5 g/day protocol.
What About Collagen?
Collagen supplements are widely marketed to women for skin, hair, and joint health. The evidence is more nuanced than the marketing suggests. Hydrolyzed collagen peptides have reasonable evidence for improving skin hydration and elasticity, with a 2019 meta-analysis finding significant effects on skin elasticity and moisture in several small RCTs. For joint pain, a UC-II undenatured collagen formulation has evidence in osteoarthritis patients. The claims for hair growth are weakest.
The honest verdict: collagen peptides are not a priority supplement unless you have specific skin or joint concerns. Vitamin D, magnesium, and omega-3 have stronger and broader evidence bases. If budget allows after addressing the priorities above, a marine or bovine collagen peptide supplement (10-15g/day) is a reasonable addition. See our collagen scorecard and our breakdown of what the collagen research actually shows. Heading into summer, our guide to supplements for UV skin support covers astaxanthin and collagen for skin going into sun season.
What the Multivitamin Won't Cover
A standard women's multivitamin is not a substitute for the supplements above. Most multivitamins provide vitamin D at 400-1,000 IU (inadequate for women with deficiency), magnesium at low doses in the oxide form (poorly absorbed), and omega-3s not at all. They are useful insurance against micronutrient gaps in diet, but they are not designed to address the specific needs of women over 40 at meaningful doses. Think of a multivitamin as a floor, not a ceiling.
What to Skip
A few supplements heavily marketed to women over 40 have weak or no evidence: saw palmetto (marketed for hair loss, evidence is for male pattern baldness only), wild yam extract (the body cannot convert diosgenin to progesterone), and most "hormone support" blends (proprietary blends with pixie-dust doses of many ingredients). If a product cannot tell you how much of each ingredient it contains, skip it. See our analysis of proprietary blends.
Evening primrose oil deserves its own line in the skip list. It is the textbook example of a women's-health supplement whose cultural reputation has outrun its data: the 2013 Cochrane review of 27 RCTs concluded oral EPO and borage oil "lack effect on eczema," the largest cyclical-mastalgia trial (Blommers 2002, n=120) found no benefit over corn-oil placebo, and 2021 meta-analyses describe it as "comparable to placebo" for breast pain. The mechanism (GLA conversion to anti-inflammatory prostaglandins) is real, but the human-endpoint data has not delivered.
Three Hormonal-Health Supplements Worth Knowing About
These are not first-line picks for most women over 40, but they each have a defensible niche and you will see them on shelves often enough that it is worth knowing the honest verdict.
Vitex (chasteberry) has the strongest evidence among hormonal-cycle herbs. Multiple RCTs (including the 2001 Schellenberg BMJ trial at n=178) support vitex for premenstrual cycle complaints and cyclical breast tenderness, with the standardized Ze 440 extract at 20 mg/day as the most-studied preparation. Vitex is contraindicated during breastfeeding (it lowers prolactin and can reduce milk supply) and during pregnancy. The evidence for menopausal hot flashes is much thinner than the marketing suggests. See our best vitex chasteberry supplement picks for products that hit the Ze 440-style 20 mg dose with verified standardization.
DIM (diindolylmethane) shifts the 2-hydroxyestrone to 16-alpha-hydroxyestrone ratio toward the 2-OH pathway, a real biomarker effect that has been replicated in multiple trials. The clinical-endpoint case (breast cancer risk reduction, hormonal acne, "estrogen dominance") is much weaker. The BR-DIM (BioResponse-DIM) absorbable form is the only version with meaningful trial evidence; generic crystalline DIM has poor bioavailability. If you are considering trying DIM on the biomarker rationale, our best DIM supplement for estrogen metabolism support ranking flags which products use the BR-DIM absorbable form and which are generic crystalline.
Myo-inositol is the strongest-evidenced inositol form for PCOS metabolic and ovulatory support, with the Genazzani 2008, Costantino 2009, and Unfer 2017 meta-analysis backing 4 g/day. Most PCOS readers will be better served by a 40:1 myo-to-D-chiro ratio product (covered on the umbrella inositol page), but pure myo-inositol is the right choice if your reproductive endocrinologist has prescribed it that way or you are using it for IVF or gestational diabetes prevention. See our best myo-inositol for PCOS ranking for products dosed to the 4 g/day clinical target.
Black cohosh is the most-studied herbal option for vasomotor symptoms in perimenopause - hot flashes and night sweats specifically. The Remifemin-standardized extract at 40 mg/day has multiple RCTs showing modest reductions in hot flash frequency, though the effect size is meaningfully smaller than menopausal hormone therapy and the 2012 Cochrane review describes the evidence as "insufficient" for a broader endorsement. Liver injury case reports have been documented but are rare; women with pre-existing liver disease should avoid it. A reasonable trial supplement before pursuing prescription options for women whose symptoms are bothersome but not severe.
FAQ
Should I take calcium supplements?
This is more complicated than it used to be. A 2019 meta-analysis in the BMJ found that calcium supplementation was not associated with reduced fracture risk in community-dwelling adults and may increase cardiovascular risk at high doses. Current guidance favors getting calcium from food (dairy, fortified plant milks, leafy greens) and ensuring adequate vitamin D and K2 to optimize what you absorb. If dietary calcium is genuinely inadequate, calcium citrate (better absorbed than carbonate) at modest doses (500 mg/day) is reasonable.
What about iron?
If you are still menstruating, iron status is worth checking. Premenopausal women have higher iron needs than men due to monthly blood loss, and iron deficiency is the most common nutritional deficiency worldwide. However, iron supplementation in women without deficiency has real downsides (constipation, oxidative stress). Get tested first; supplement only if deficient. See our iron scorecard.
Can I take all these at once?
You can, with some sequencing. Take vitamin D3 and omega-3 with your largest meal (fat improves absorption). Take magnesium glycinate separately at bedtime. B12 can be taken at any time. Ashwagandha is commonly taken in the morning or before bed - both appear to work. Iron, if needed, should be taken on an empty stomach or with vitamin C, separate from calcium, magnesium, and zinc which compete for absorption.
Sources
- Abbasi B, Kimiagar M, et al. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161-9. PubMed
- Bernstein AM, Ding EL, et al. A meta-analysis shows that omega-3 fatty acids reduce triglycerides and cardiovascular events. J Nutr. 2012;142(1):99-104. PubMed
- Manson JE, Cook NR, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease (VITAL trial). N Engl J Med. 2019;380(1):33-44. PubMed
These statements have not been evaluated by the FDA. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.